Tech Company Financing Transactions
Outset Medical Funding Round
On 2/6/2020, Outset Medical raised $125 million in Series E funding from D1 Capital Partners, Fidelity Management & Research Company and Partner Fund Management.
Transaction Overview
Company Name
Announced On
2/6/2020
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series E
Investors
D1 Capital Partners (Lead Investor) (Daniel Sundheim)
Proceeds Purpose
Proceeds will be used to support commercial expansion of Outset Medical's Tablo Hemodialysis System across the acute and chronic care markets in the United States.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
3052 Orchard Dr.
San Jose, CA 95134
USA
San Jose, CA 95134
USA
Phone
Website
Email Address
Overview
Outset Medical (Nasdaq: OM). Dialysis has remained largely unchanged for decades -- until now. Tablo is a new hemodialysis system designed to put the patient before the machine. A system designed for simplicity. A system designed for flexibility. A system truly designed for people like Reggie Boyd, Jr., guitarist, composer and kidney patient.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leslie Trigg
Chief Financial Officer
Rebecca Chambers
Chief Medical Officer
Michael Aragon
Chief Operating Officer
Martin Vazquez
Browse more venture capital transactions:
Prev: 2/6/2020: Adarza BioSystems venture capital transaction
Next: 2/6/2020: Maven Machines venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. VC transactions on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs